Navigation Links
Beactica Announces Drug Discovery Agreement With Cubist Pharmaceuticals
Date:5/25/2009

UPPSALA, Sweden, May 25 /PRNewswire/ -- Beactica AB, the Swedish fragment-based drug discovery company, today announced that it has entered into an agreement with Cubist Pharmaceuticals, Inc. (Lexington, MA; NASDAQ: CBST). Under the agreement, Beactica will use its Sprint(TM) surface plasmon resonance (SPR)-integrated drug discovery platform to target multi-component proteins from pathogenic bacteria of interest to Cubist. Financial terms of the agreement were not disclosed.

"We are pleased to be working with Cubist in their quest to develop next-generation anti-bacterials" said Beactica CEO, Dr Per Kallblad. "Cubist has excellent strengths in the area and it is a source of pride to have been selected to help progress one of their discovery programmes."

Cubist becomes the fifth life-science company to enter an agreement with Beactica in the past eighteen months.

About Beactica

Beactica AB is a specialist drug discovery company, utilising its proprietary methodologies to evaluate the biophysical interaction of molecules in order to generate novel therapeutics. Beactica's Sprint(TM) drug discovery platform efficiently integrates surface plasmon resonance (SPR) to accelerate the identification of optimal starting points and development routes for lead discovery. The company was spun out of Uppsala University in August 2006. As well as building collaborations with external companies, Beactica is progressing its own drug discovery programmes of small molecule therapeutics. For more information about Beactica, please visit http://www.beactica.com.


'/>"/>
SOURCE Beactica AB
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. New Fragment-based Drug Discovery Platform Announced Between IOTA Pharmaceuticals Ltd, Cambridge (UK), and Beactica AB, Uppsala (Sweden)
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
4. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
5. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
6. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
7. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/14/2017)... ... 14, 2017 , ... Opal Kelly, a leading producer of ... announced the release of SYZYGY™, a new open standard for connecting high-performance peripherals ... compact, low cost, low pin-count, high-performance connectivity solution between FPGAs and single-purpose hardware ...
(Date:8/11/2017)... Calif. (PRWEB) , ... August 11, 2017 , ... Algenist ... plant collagen-based formulation unlocking collagen like never before. , Collagen is the key ... firsts to market with Liquid Collagen™, which include: , ...
(Date:8/10/2017)... , ... August 09, 2017 , ... ... medicine applications in the clinic is here. The team at Capricor Therapeutics, Inc. ... conditioned medium for clinical studies. , Dr. Travis Antes, head of analytical ...
(Date:8/10/2017)... (PRWEB) , ... August 10, 2017 , ... DrugDev ... new educational webinar to demonstrate how Good Clinical Practice (GCP) can be ... documents. In addition the webinar will discuss the importance of GCP compliance, how sites ...
Breaking Biology Technology:
(Date:6/23/2017)... and ITHACA, N.Y. , June ... Cornell University, a leader in dairy research, today announced ... designed to help reduce the chances that the global ... onset of this dairy project, Cornell University has become ... Sequencing the Food Supply Chain, a food safety initiative ...
(Date:5/23/2017)...  Hunova, the first robotic gym for the rehabilitation and functional motor ... Genoa, Italy . The first 30 robots will be ... USA . The technology was developed and patented at the ... spin-off Movendo Technology thanks to a 10 million euro investment from entrepreneur ... ...
(Date:5/16/2017)... , May 16, 2017   Bridge Patient ... organizations, and MD EMR Systems , an ... partner for GE, have established a partnership to ... product and the GE Centricity™ products, including Centricity ... These new integrations will allow ...
Breaking Biology News(10 mins):